Exagen

IPO

Exagen Inc. - Autoimmune Disease Testing Lab - Rheumatology Lab

Public · Vista, United States · Founded 2002 · $82.9M raised

Headquarters
Vista
Employees
51–200
Founded
2002
Business Model
B2B
Website
exagen.com
Total Funding
$82.9M
Last Round
$48.0M Series FJan 2015
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 5 investors for this company. The full record is or through the API.

About

Exagen is dedicated to transforming the care continuum for patients suffering from debilitating chronic autoimmune diseases. Its innovative AVISE product portfolio enables timely differential diagnosis, prognosis, management, and optimization of therapeutic intervention. AVISE CTD uses scientifically proven CB-CAPs technology to help rheumatologists distinguish connective tissue diseases with overlapping symptoms, while AVISE SLE Prognostic assesses risk for organ involvement. The company's mission is to provide clarity in autoimmune disease decision making and improve patients' clinical outcomes.

Summary

Exagen is a Healthcare company based in Vista, United States, founded in 2002. It has raised $82.9M in total across 4 rounds, most recently a $48.0M Series F round in Jan 2015. Investors include Mesa Verde Venture Partners, Tullis Health Investors and Innovatus Capital Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOSep 2019
$58.0M

Sign up to see all 6 events

Funding: Series B through Series F. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Exagen on Indexed.vc
<a href="https://indexed.vc/companies/exagen"><img src="https://indexed.vc/api/badge/company/exagen" alt="Exagen on Indexed.vc" width="260" height="76" /></a>